Morningside Venture Investments Ltd

Overview

• HeadquartersDE¹

See how the biggest companies compare on our leaderboards

Corporate structure

Morningside Venture Investments Ltd sits at the top of its group. 9 entities, 2 countries on record. Switch between the flow chart and the network, and select any entity to see its details.

Built from major holders from Schedules 13D and 13G; stakes of 5% or more it reported on Schedules 13D and 13G (8 companies). Each entity in the chart links to its source.

Stakes it holds

Morningside Venture Investments Ltd has told the SEC it owns more than 5% of 8 companies, latest first (Schedules 13D and 13G).

• Kezar Life Sciences, Inc.SCHEDULE 13D/A Aug 17, 2023 to Jan 16, 2025²
• Amylyx PharmaceuticalsSC 13D/A Jan 25, 2022 to Oct 4, 2023³
• NewAmsterdam Pharma Co N.V.SC 13G/A Dec 2, 2022 to Sep 20, 2023⁴
• GreenLight Biosciences Holdings, PBCSC 13D/A Feb 14, 2022 to Jul 25, 2023⁵
• LumiraDx LtdSC 13D/A Feb 14, 2022 to Feb 23, 2023⁶
• Atea Pharmaceuticals, Inc.SC 13G/A Feb 16, 2022⁷
• Apellis Pharmaceuticals, Inc.SC 13G/A Feb 14, 2022⁸
• Stealth BioTherapeutics CorpSC 13D/A Nov 22, 2021⁹